8QQ-84843-73539
4 vaccinations
1 coded response
49 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 040 / ME
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WQA-24283-63080
Child or adolescent in my care · Female · 2022-06-28
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Pfizer-BioNTech
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-15
- 2021-04-22
-
2021-04-29
Dose 2 — Pfizer-BioNTech
- 2021-04-29
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-07-30
- 2021-10-28
-
2021-12-09
Dose 3 — Moderna
- 2021-12-09
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-12-12
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Abdominal pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-12-14
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-15
- 2021-12-15
-
2021-12-16
Survey response — day 7, dose 3MedDRA: Vision blurred — Feeling: GoodFree text: Temporary Blurry visionMedDRA releases: 2024-11 · check-in free text available
- 2021-12-23
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-03-10
- 2022-06-09
- 2022-12-09
-
2022-12-21
Dose 4 — Moderna
-
2022-12-22
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-12-23
- 2022-12-24
- 2022-12-26
- 2022-12-27
- 2022-12-28
- 2023-01-04
- 2023-01-18
- 2023-01-25
- 2023-02-01
- 2023-06-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Moderna | No |
| 4 | 2022-12-21 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 7, dose 3
Systemic reaction (other): Temporary Blurry vision
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release